LI, C. et al. A Novel Multi-analyte Serum Panel Combining CA-125, HE4, microRNA-200a, and Interleukin-6 for the Preclinical Detection of High-Grade Serous Ovarian Carcinoma in Women with Pathogenic *BRCA1/2* Variants: Serum CA-125, HE4, microRNA-200a, and Interleukin- Serous Ovarian Carcinoma. Journal of Medical Biochemistry, 1 June2026.